Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial

Lipid Levels ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Nigella Sativa Seed ◽

Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Results from a randomized, double-blind, placebo-controlled, clinical trial

Complementary Therapies in Medicine ◽

10.1016/j.ctim.2019.04.014 ◽

2019 ◽

Vol 44 ◽

pp. 204-209 ◽

Cited By ~ 4

Author(s):

Mina Darand ◽

Zahra Darabi ◽

Zahra Yari ◽

Saeedeh Saadati ◽

Mehdi Hedayati ◽

...

Keyword(s):

Clinical Trial ◽

Liver Disease ◽

Fatty Liver Disease ◽

Nigella Sativa ◽

Inflammatory Biomarkers ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial

European Journal of Nutrition ◽

10.1007/s00394-019-01916-7 ◽

2019 ◽

Vol 59 (2) ◽

pp. 477-483 ◽

Cited By ~ 10

Author(s):

Arrigo F. G. Cicero ◽

Amirhossein Sahebkar ◽

Federica Fogacci ◽

Marilisa Bove ◽

Marina Giovannini ◽

...

Keyword(s):

Insulin Resistance ◽

Clinical Trial ◽

Liver Disease ◽

Fatty Liver Disease ◽

Anthropometric Parameters ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial

BMC Complementary and Alternative Medicine ◽

10.1186/s12906-019-2465-0 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 6

Author(s):

Milad Daneshi-Maskooni ◽

Seyed Ali Keshavarz ◽

Mostafa Qorbani ◽

Siavash Mansouri ◽

Seyed Moayed Alavian ◽

...

Keyword(s):

Clinical Trial ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Lipid Profiles ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Green Cardamom ◽

Efficacy of Black Seed (Nigella sativa) and Lemon Balm (Melissa officinalis) on Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial

Iranian Red Crescent Medical Journal ◽

10.5812/ircmj.59183 ◽

2018 ◽

Vol 20 (3) ◽

Cited By ~ 2

Author(s):

Seyed Mousal-Reza Hosseini ◽

Gholam Reza Ghayour Razmgah ◽

Mohsen Nematy ◽

Habibollah Esmaily ◽

Mahdi Yousefi ◽

...

Keyword(s):

Clinical Trial ◽

Fatty Liver Disease ◽

Nigella Sativa ◽

Randomized Controlled Clinical Trial ◽

Melissa Officinalis ◽

Alcoholic Fatty Liver ◽

Lemon Balm ◽

Randomized Controlled ◽

Effects of Supplementation with Main Coffee Components on Hepatic, Metabolic, and Inflammatory Indices in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3397199 ◽

2019 ◽

Cited By ~ 1

Author(s):

Asieh Mansour ◽

Mohammad Reza Mohajeri-Tehrani ◽

Majid Samadi ◽

Mostafa Qorbani ◽

Shahin Merat ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Liver Disease ◽

Fatty Liver Disease ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Effects Phytosomal Curcumin On Anthropometric Parameters, Insulin-Resistance, Cortisolemia And Non-Alcoholic Fatty Liver Disease Indexes: A Double-Blind, Placebo-Controlled Clinical Trial

Atherosclerosis ◽

10.1016/j.atherosclerosis.2019.06.443 ◽

2019 ◽

Vol 287 ◽

pp. e149

Author(s):

A. Cicero ◽

A. Sahebkar ◽

F. Fogacci ◽

M. Bove ◽

M. Giovannini ◽

...

Keyword(s):

Insulin Resistance ◽

Clinical Trial ◽

Liver Disease ◽

Fatty Liver Disease ◽

Anthropometric Parameters ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial

Archives of Disease in Childhood ◽

10.1136/adc.2010.192401 ◽

2011 ◽

Vol 96 (4) ◽

pp. 350-353 ◽

Cited By ~ 165

Author(s):

V. Nobili ◽

G. Bedogni ◽

A. Alisi ◽

A. Pietrobattista ◽

P. Rise ◽

...

Keyword(s):

Clinical Trial ◽

Fatty Liver Disease ◽

Liver Fat ◽

Liver Fat Content ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Randomised Controlled Clinical Trial ◽

Randomised Controlled ◽

Effects of Alpha-Lipoic Acid Supplementation on Oxidative Stress Status in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double Blind, Placebo-Controlled Clinical Trial

Iranian Red Crescent Medical Journal ◽

10.5812/ircmj.67615 ◽

2018 ◽

Vol 20 (9) ◽

Cited By ~ 3

Author(s):

Farshad Amirkhizi ◽

Soudabeh Hamedi-Shahraki ◽

Sonya Hosseinpour-Arjmand ◽

Elnaz Vaghef-Mehrabany ◽

Mehrangiz Ebrahimi-Mameghani

Keyword(s):

Oxidative Stress ◽

Clinical Trial ◽

Fatty Liver Disease ◽

Alpha Lipoic Acid ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Oxidative Stress Status ◽

Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Diabetes Therapy ◽

10.1007/s13300-021-01011-3 ◽

2021 ◽

Vol 12 (3) ◽

pp. 843-861

Author(s):

Haleh Chehrehgosha ◽

Masoud Reza Sohrabi ◽

Faramarz Ismail-Beigi ◽

Mojtaba Malek ◽

Mohammad Reza Babaei ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Fatty Liver Disease ◽

Liver Steatosis ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial

BMC Research Notes ◽

10.1186/s13104-019-4130-6 ◽

2019 ◽

Vol 12 (1) ◽

Cited By ~ 7

Author(s):

Zahra Darabi ◽

Mina Darand ◽

Zahra Yari ◽

Mehdi Hedayati ◽

Amirhosein Faghihi ◽

...

Keyword(s):

Clinical Trial ◽

Liver Disease ◽

Fatty Liver ◽

Inflammatory Markers ◽

Fatty Liver Disease ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽